Table 6 |
|||||
|
Blood Pressure, Fasting Glucose. |
|||||
| Group |
Time 0 |
4 weeks |
8 weeks |
%Δ0–4 wks |
%Δ0–8 wks |
| OP |
|||||
| Systolic BP |
130.8 |
1.31 ± 12.07 |
2.15 ± 8.66 |
1.0 |
1.6 |
| Diastolic BP |
81.8 |
-3.46 ± 7.47 |
-2.31 ± 8.62 |
-4.2 |
-2.8 |
| Glucose |
113.8 |
0.14 ± 7.77 |
-9.64 ± 8.99 |
0.2 |
-10.7 |
| OT |
|||||
| Systolic BP |
135.1 |
-4.43 ± 8.66 |
-8.07 ± 11.13 |
-3.3* |
-6.0* |
| Diastolic BP |
82.7 |
-6.86 ± 6.98 |
-10.85 ± 9.00 |
-8.3* |
-13.1* |
| Glucose |
73.4 |
-8.58 ± 11.28 |
-17.67 ± 11.69 |
-9.5* |
-19.6* |
| NP |
|||||
| Systolic BP |
127.0 |
-5.66 ± 9.56 |
-6.66 ± 8.08 |
-4.5 |
-5.3* |
| Diastolic BP |
84.7 |
-7.55 ± 2.07 |
-10.50 ± 5.40 |
-8.85* |
-12.39* |
| Glucose |
57.6 |
-0.18 ± 5.6 |
-0.02 ± 3.98 |
-0.3 |
-0.0 |
| NT |
|||||
| Systolic BP |
126.6 |
2.90 ± 12.60 |
-2.30 ± 9.21 |
2.3 |
-1.8 |
| Diastolic BP |
81.2 |
-7.36 ± 9.34 |
-9.45 ± 9.96 |
-9.1* |
-11.6* |
| Glucose |
56.9 |
-0.62 ± 5.83 |
-3.27 ± 7.59 |
-0.9 |
-4.8 |
|
|
|||||
|
*Significant P values < 0.05. OP = overweight placebo, OT = overweight treatment, NP = normal weight placebo and NT = normal weight treatment. Values at the start of the study (Time 0) listed in the first column are means of data from individuals. Mean changes after 4 weeks and 8 weeks are listed in the second and third columns as ± Standard Deviation. A negative value indicated a decrease in value and a positive number represents an increase in value. %Δ values are percent mean change in value between time 0 and either 4 or 8 weeks. Values* are significant P-value comparisons (< 0.05) between initial values at Time 0 and either 4 weeks or 8 weeks. The unit of measurement for blood pressure is mmHg and for glucose is mg/dl. |
|||||
|
Oben et al. Nutrition Journal 2008 7:16 doi:10.1186/1475-2891-7-16 |
|||||
